Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$722K Buy
1,409
+527
+60% +$277K 0.01% 330
2022
Q3
$428K Buy
882
+224
+34% +$109K ﹤0.01% 359
2022
Q2
$308K Sell
658
-730
-53% -$325K ﹤0.01% 407
2022
Q1
$604K Buy
1,388
+670
+93% +$280K 0.01% 386
2021
Q4
$333K Sell
718
-1,104
-61% -$489K ﹤0.01% 478
2021
Q3
$709K Buy
1,822
+394
+28% +$167K 0.01% 373
2021
Q2
$632K Buy
1,428
+426
+43% +$186K 0.01% 388
2021
Q1
$420K Sell
1,002
-5,350
-84% -$2.14M ﹤0.01% 425
2020
Q4
$2.61M Sell
6,352
-3,147
-33% -$1.31M 0.03% 180
2020
Q3
$3.93M Sell
9,499
-2,396
-20% -$964K 0.05% 112
2020
Q2
$4.61M Sell
11,895
-9,654
-45% -$3.61M 0.06% 112
2020
Q1
$6.77M Sell
21,549
-14,762
-41% -$4.98M 0.12% 77
2019
Q4
$13.3M Buy
36,311
+29,648
+445% +$9.4M 0.17% 67
2019
Q3
$1.7M Sell
6,663
-22,825
-77% -$6.4M 0.02% 233
2019
Q2
$7.82M Sell
29,488
-61,977
-68% -$15.7M 0.11% 93
2019
Q1
$21M Sell
91,465
-5,829
-6% -$1.68M 0.29% 59
2018
Q4
$24M Buy
97,294
+10,915
+13% +$3.46M 0.38% 55
2018
Q3
$29.2M Sell
86,379
-14,170
-14% -$4.6M 0.4% 50
2018
Q2
$29.9M Buy
100,549
+15,125
+18% +$4.43M 0.39% 51
2018
Q1
$23M Buy
85,424
+10,337
+14% +$2.8M 0.3% 54
2017
Q4
$18.6M Buy
75,087
+14,722
+24% +$3.64M 0.24% 67
2017
Q3
$14.7M Buy
60,365
+2,143
+4% +$525K 0.19% 90
2017
Q2
$14M Buy
+58,222
New +$13.2M 0.2% 89

Other funds holding HUM

Pendal Group's HUM Position: Q4 2022 in Review

Pendal Group increased its Humana (HUM) stake by 60% in Q4 2022, buying an estimated $277K and bringing the position to 1,409 shares worth $722K. The position accounts for 0.01% of the portfolio, ranked #330.

Pendal Group first reported a position in HUM in Q2 2017 and has held it in 23 quarters since. The position peaked at $29.9M in Q2 2018. 1,078 funds tracked by Wall St. Rank hold HUM as of Q4 2022.

  • Pendal Group held 1,409 shares of Humana worth $722K as of Q4 2022.
  • Pendal Group bought 527 Humana shares in Q4 2022, an estimated $277K.
  • Humana made up 0.01% of Pendal Group's portfolio in Q4 2022, its #330 holding.
  • Pendal Group first reported a position in Humana in Q2 2017 and has held it in 23 quarters since.
  • Pendal Group's Humana position peaked at $29.9M in Q2 2018.
  • 1,078 funds tracked by Wall St. Rank held Humana as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.